Demonstrating performance in scaled-up production and quality control of polyhydroxyalkanoates using municipal waste activated sludge.

Water Res

Department of Biotechnology, Delft University of Technology, Delft, The Netherlands; Wetsus, European Centre of Excellence for Sustainable Water Technology, Leeuwarden, The Netherlands; School of Chemical Engineering, University of Queensland, St. Lucia, Australia. Electronic address:

Published: January 2025

Significant progress has been made over the past decade with pilot scale polyhydroxyalkanoate (PHA) production by direct accumulation using municipal waste activated sludge (WAS). However, industrial upscaling experiences are still lacking in the research literature. In this study, a demonstration scale (4 m) PHA production process was operated using industrially relevant equipment and compared favourably to those from parallel pilot scale (200 L) production runs. WAS grab samples from a Dutch full scale municipal wastewater treatment plant (WWTP) was used as the biomass source. Final biomass PHA contents and production yields, that are critical for technology viability, were statistically the same between the experiments conducted at pilot scale (0.41 ± 0.02 gPHA/gVSS and 0.42 ± 0.02 gCOD/gCOD) and demonstration scale (0.45 ± 0.05 gPHA/gVSS and 0.39 ± 0.07 gCOD/gCOD). The results furthermore aligned with previous 1 m piloting experiences and five year old historical data that similarly used WAS sourced from the same WWTP. Scalability for the technology and a robustness of the applied PHA production methods using WAS were demonstrated. Temperature and foaming control were identified to be critical to upscaled process engineering and design towards successful industrial implementations. The results of the present study, combined with previously produced PHAs and those historical data, support that feedstock quality predictably determines both the average PHA co-monomer content, as well as the blend distribution. PHA solvent extraction from WAS is inherently a blending process. Extraction homogeneously mixes polymer contributions from collectively stored granules from all species of microorganisms in the biomass. Dried PHA-rich biomass batches can be stockpiled and batches can be blended in extraction processes for both recovery and formulation to reach consistent polymer qualities across production batches. More centralized extraction facilities are therefore anticipated to offer economic benefits due to scale and greater opportunities for product quality specification and control. Research findings are presented herein of the production scale comparative study along with practical perspectives of technological readiness for realizing WAS based industrial scale PHA production, quality control, and the supply chains that will be necessary for successful commercial implementation.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.watres.2025.123160DOI Listing

Publication Analysis

Top Keywords

pha production
16
pilot scale
12
production
9
scale
9
production quality
8
quality control
8
municipal waste
8
waste activated
8
activated sludge
8
demonstration scale
8

Similar Publications

Demonstrating performance in scaled-up production and quality control of polyhydroxyalkanoates using municipal waste activated sludge.

Water Res

January 2025

Department of Biotechnology, Delft University of Technology, Delft, The Netherlands; Wetsus, European Centre of Excellence for Sustainable Water Technology, Leeuwarden, The Netherlands; School of Chemical Engineering, University of Queensland, St. Lucia, Australia. Electronic address:

Significant progress has been made over the past decade with pilot scale polyhydroxyalkanoate (PHA) production by direct accumulation using municipal waste activated sludge (WAS). However, industrial upscaling experiences are still lacking in the research literature. In this study, a demonstration scale (4 m) PHA production process was operated using industrially relevant equipment and compared favourably to those from parallel pilot scale (200 L) production runs.

View Article and Find Full Text PDF

Polyhydroxyalkanoates (PHA) are bioplastics produced by few bacteria as intracellular lipid inclusions under excess carbon source and nutrient-deprived conditions. These polymers are biodegradable and resemble petroleum-based plastics. The rising environmental concerns have increased the demand for PHA, but the low yield in wild-type bacterial strains limits large-scale production.

View Article and Find Full Text PDF

Enhanced production, functionalization, and applications of polyhydroxyalkanoates from organic waste: A review.

Int J Biol Macromol

January 2025

Department of Chemical and Environmental Engineering and Pro-Vice-Chancellor (Planning & Resources), University of Mauritius, Reduit, Mauritius.

Polyhydroxyalkanoates (PHAs) represent a promising class of biodegradable polyesters synthesized by various microorganisms as energy storage compounds. Their versatility and environmental friendliness make them potential candidates for replacing conventional plastics across numerous applications. However, challenges such as limited mechanical properties, high production costs, and thermal instability have hindered their widespread adoption.

View Article and Find Full Text PDF

The products of an advanced sewage sludge fermentation process can be used to generate polyhydroxyalkanoates (PHAs), precursors of bioplastics considered excellent candidates for replacing petroleum-derived plastics. The aerobic feast-anoxic famine cycling strategy has proven to be an efficient method for enriching sewage sludge microbiota with PHA-producing microorganisms. This work evaluated the effect of different carbon to nitrogen ratios (C/N) of 3.

View Article and Find Full Text PDF

Introduction: The Quality by Design (QbD) approach for developing cell therapy products using mesenchymal stromal/stem cells (MSCs) is a promising method for designing manufacturing processes to improve the quality of MSC products. It is crucial to ensure the reproducibility and robustness of the test system for evaluating critical quality attributes (CQAs) in the QbD approach for manufacturing of pharmaceutical products. In this study, we explored the key factors involved in establishing a robust evaluation system for the immunosuppressive effect of MSCs, which can be an example of a CQA in developing and manufacturing therapeutic MSCs for treating graft-versus-host disease, , and we have identified method attributes to increase the robustness of a simple assay to assess the immunosuppressive effects of MSCs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!